nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Citalopram—alcohol dependence	0.18	0.443	CbGbCtD
Imiquimod—CYP3A4—Disulfiram—alcohol dependence	0.132	0.325	CbGbCtD
Imiquimod—CYP3A4—Citalopram—alcohol dependence	0.0944	0.232	CbGbCtD
Imiquimod—TLR8—blood—alcohol dependence	0.0101	0.147	CbGeAlD
Imiquimod—TLR8—endocrine gland—alcohol dependence	0.00875	0.127	CbGeAlD
Imiquimod—TLR8—liver—alcohol dependence	0.00789	0.115	CbGeAlD
Imiquimod—TLR7—gonad—alcohol dependence	0.0073	0.106	CbGeAlD
Imiquimod—TLR7—blood—alcohol dependence	0.00636	0.0926	CbGeAlD
Imiquimod—TLR7—endocrine gland—alcohol dependence	0.00552	0.0803	CbGeAlD
Imiquimod—TLR7—testis—alcohol dependence	0.00526	0.0766	CbGeAlD
Imiquimod—TLR7—liver—alcohol dependence	0.00497	0.0724	CbGeAlD
Imiquimod—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00453	0.057	CbGpPWpGaD
Imiquimod—TLR7—brain—alcohol dependence	0.00395	0.0575	CbGeAlD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00376	0.0473	CbGpPWpGaD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00312	0.0392	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.0029	0.0365	CbGpPWpGaD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00265	0.0333	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00241	0.0302	CbGpPWpGaD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00225	0.0283	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00205	0.0257	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00198	0.0249	CbGpPWpGaD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00198	0.0248	CbGpPWpGaD
Imiquimod—CYP1A2—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00188	0.0237	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00174	0.0219	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00153	0.0192	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00153	0.0192	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.0015	0.0189	CbGpPWpGaD
Imiquimod—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00145	0.0183	CbGpPWpGaD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00139	0.0175	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—WASF2—alcohol dependence	0.00127	0.016	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—WASF1—alcohol dependence	0.00122	0.0153	CbGpPWpGaD
Imiquimod—CYP1A2—digestive system—alcohol dependence	0.0012	0.0175	CbGeAlD
Imiquimod—CYP1A2—blood—alcohol dependence	0.00115	0.0167	CbGeAlD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00111	0.014	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00107	0.0135	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00106	0.0133	CbGpPWpGaD
Imiquimod—Sweating increased—Naltrexone—alcohol dependence	0.00101	0.00228	CcSEcCtD
Imiquimod—Erectile dysfunction—Acamprosate—alcohol dependence	0.00101	0.00228	CcSEcCtD
Imiquimod—Photosensitivity reaction—Acamprosate—alcohol dependence	0.001	0.00226	CcSEcCtD
Imiquimod—Bronchitis—Naltrexone—alcohol dependence	0.001	0.00225	CcSEcCtD
Imiquimod—CYP1A2—endocrine gland—alcohol dependence	0.000993	0.0145	CbGeAlD
Imiquimod—Vaginal infection—Citalopram—alcohol dependence	0.000992	0.00223	CcSEcCtD
Imiquimod—Depression—Acamprosate—alcohol dependence	0.000978	0.0022	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.000967	0.00217	CcSEcCtD
Imiquimod—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000966	0.00217	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—WASF2—alcohol dependence	0.000963	0.0121	CbGpPWpGaD
Imiquimod—Myocardial infarction—Acamprosate—alcohol dependence	0.000961	0.00216	CcSEcCtD
Imiquimod—Urinary tract infection—Acamprosate—alcohol dependence	0.000953	0.00214	CcSEcCtD
Imiquimod—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.000931	0.0117	CbGpPWpGaD
Imiquimod—Infestation NOS—Naltrexone—alcohol dependence	0.000928	0.00209	CcSEcCtD
Imiquimod—Infestation—Naltrexone—alcohol dependence	0.000928	0.00209	CcSEcCtD
Imiquimod—Depression—Naltrexone—alcohol dependence	0.000925	0.00208	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—WASF1—alcohol dependence	0.000923	0.0116	CbGpPWpGaD
Imiquimod—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000914	0.00206	CcSEcCtD
Imiquimod—Asthenia—Disulfiram—alcohol dependence	0.000911	0.00205	CcSEcCtD
Imiquimod—Myocardial infarction—Naltrexone—alcohol dependence	0.000909	0.00205	CcSEcCtD
Imiquimod—Conjunctivitis—Naltrexone—alcohol dependence	0.000902	0.00203	CcSEcCtD
Imiquimod—Urinary tract infection—Naltrexone—alcohol dependence	0.000902	0.00203	CcSEcCtD
Imiquimod—CYP1A2—liver—alcohol dependence	0.000896	0.013	CbGeAlD
Imiquimod—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000896	0.0113	CbGpPWpGaD
Imiquimod—Lymphadenopathy—Citalopram—alcohol dependence	0.000894	0.00201	CcSEcCtD
Imiquimod—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000891	0.0112	CbGpPWpGaD
Imiquimod—Haemoglobin—Acamprosate—alcohol dependence	0.000885	0.00199	CcSEcCtD
Imiquimod—Rhinitis—Acamprosate—alcohol dependence	0.000882	0.00198	CcSEcCtD
Imiquimod—Haemorrhage—Acamprosate—alcohol dependence	0.00088	0.00198	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000878	0.011	CbGpPWpGaD
Imiquimod—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000877	0.00197	CcSEcCtD
Imiquimod—Pharyngitis—Acamprosate—alcohol dependence	0.000873	0.00196	CcSEcCtD
Imiquimod—Sinusitis—Naltrexone—alcohol dependence	0.00087	0.00196	CcSEcCtD
Imiquimod—CYP3A4—digestive system—alcohol dependence	0.00087	0.0127	CbGeAlD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000859	0.0108	CbGpPWpGaD
Imiquimod—Eczema—Citalopram—alcohol dependence	0.000849	0.00191	CcSEcCtD
Imiquimod—Visual impairment—Acamprosate—alcohol dependence	0.000848	0.00191	CcSEcCtD
Imiquimod—Dizziness—Disulfiram—alcohol dependence	0.000839	0.00189	CcSEcCtD
Imiquimod—Nasal congestion—Citalopram—alcohol dependence	0.000837	0.00188	CcSEcCtD
Imiquimod—Injury—Citalopram—alcohol dependence	0.00083	0.00187	CcSEcCtD
Imiquimod—CYP3A4—blood—alcohol dependence	0.000829	0.0121	CbGeAlD
Imiquimod—Pharyngitis—Naltrexone—alcohol dependence	0.000826	0.00186	CcSEcCtD
Imiquimod—Tinnitus—Acamprosate—alcohol dependence	0.000821	0.00185	CcSEcCtD
Imiquimod—Connective tissue disorder—Naltrexone—alcohol dependence	0.000818	0.00184	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000818	0.0103	CbGpPWpGaD
Imiquimod—Atrial fibrillation—Citalopram—alcohol dependence	0.000805	0.00181	CcSEcCtD
Imiquimod—Rash—Disulfiram—alcohol dependence	0.0008	0.0018	CcSEcCtD
Imiquimod—Headache—Disulfiram—alcohol dependence	0.000795	0.00179	CcSEcCtD
Imiquimod—Immune system disorder—Acamprosate—alcohol dependence	0.000795	0.00179	CcSEcCtD
Imiquimod—Purpura—Citalopram—alcohol dependence	0.000791	0.00178	CcSEcCtD
Imiquimod—Chills—Acamprosate—alcohol dependence	0.00079	0.00178	CcSEcCtD
Imiquimod—Arthritis—Citalopram—alcohol dependence	0.000785	0.00177	CcSEcCtD
Imiquimod—Cardiac failure—Citalopram—alcohol dependence	0.000781	0.00176	CcSEcCtD
Imiquimod—Lethargy—Citalopram—alcohol dependence	0.000778	0.00175	CcSEcCtD
Imiquimod—Cerebrovascular accident—Citalopram—alcohol dependence	0.000778	0.00175	CcSEcCtD
Imiquimod—Eye disorder—Naltrexone—alcohol dependence	0.000778	0.00175	CcSEcCtD
Imiquimod—Alopecia—Acamprosate—alcohol dependence	0.000778	0.00175	CcSEcCtD
Imiquimod—Tinnitus—Naltrexone—alcohol dependence	0.000776	0.00175	CcSEcCtD
Imiquimod—Mental disorder—Acamprosate—alcohol dependence	0.000771	0.00173	CcSEcCtD
Imiquimod—Malnutrition—Acamprosate—alcohol dependence	0.000766	0.00172	CcSEcCtD
Imiquimod—Pain in extremity—Citalopram—alcohol dependence	0.000763	0.00172	CcSEcCtD
Imiquimod—Angiopathy—Naltrexone—alcohol dependence	0.000755	0.0017	CcSEcCtD
Imiquimod—Immune system disorder—Naltrexone—alcohol dependence	0.000752	0.00169	CcSEcCtD
Imiquimod—Migraine—Citalopram—alcohol dependence	0.000751	0.00169	CcSEcCtD
Imiquimod—Mediastinal disorder—Naltrexone—alcohol dependence	0.00075	0.00169	CcSEcCtD
Imiquimod—Chills—Naltrexone—alcohol dependence	0.000747	0.00168	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000746	0.00938	CbGpPWpGaD
Imiquimod—Back pain—Acamprosate—alcohol dependence	0.000741	0.00167	CcSEcCtD
Imiquimod—TLR8—Immune System—WASF2—alcohol dependence	0.00074	0.0093	CbGpPWpGaD
Imiquimod—Face oedema—Citalopram—alcohol dependence	0.000736	0.00166	CcSEcCtD
Imiquimod—Alopecia—Naltrexone—alcohol dependence	0.000736	0.00166	CcSEcCtD
Imiquimod—Mental disorder—Naltrexone—alcohol dependence	0.00073	0.00164	CcSEcCtD
Imiquimod—Irritability—Citalopram—alcohol dependence	0.000728	0.00164	CcSEcCtD
Imiquimod—Urinary retention—Citalopram—alcohol dependence	0.000725	0.00163	CcSEcCtD
Imiquimod—Malnutrition—Naltrexone—alcohol dependence	0.000725	0.00163	CcSEcCtD
Imiquimod—CYP3A4—endocrine gland—alcohol dependence	0.000719	0.0105	CbGeAlD
Imiquimod—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000719	0.00903	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Acamprosate—alcohol dependence	0.000711	0.0016	CcSEcCtD
Imiquimod—TLR8—Immune System—WASF1—alcohol dependence	0.00071	0.00892	CbGpPWpGaD
Imiquimod—Agitation—Acamprosate—alcohol dependence	0.000704	0.00158	CcSEcCtD
Imiquimod—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.000704	0.00884	CbGpPWpGaD
Imiquimod—Back pain—Naltrexone—alcohol dependence	0.000701	0.00158	CcSEcCtD
Imiquimod—Angioedema—Acamprosate—alcohol dependence	0.0007	0.00157	CcSEcCtD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000691	0.00868	CbGpPWpGaD
Imiquimod—Malaise—Acamprosate—alcohol dependence	0.000691	0.00155	CcSEcCtD
Imiquimod—Breast disorder—Citalopram—alcohol dependence	0.000689	0.00155	CcSEcCtD
Imiquimod—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000687	0.00864	CbGpPWpGaD
Imiquimod—Syncope—Acamprosate—alcohol dependence	0.000687	0.00155	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000678	0.00851	CbGpPWpGaD
Imiquimod—Palpitations—Acamprosate—alcohol dependence	0.000677	0.00152	CcSEcCtD
Imiquimod—Loss of consciousness—Acamprosate—alcohol dependence	0.000673	0.00151	CcSEcCtD
Imiquimod—CYP3A4—nervous system—alcohol dependence	0.000673	0.0098	CbGeAlD
Imiquimod—Ill-defined disorder—Naltrexone—alcohol dependence	0.000673	0.00151	CcSEcCtD
Imiquimod—Cough—Acamprosate—alcohol dependence	0.000669	0.0015	CcSEcCtD
Imiquimod—Agitation—Naltrexone—alcohol dependence	0.000666	0.0015	CcSEcCtD
Imiquimod—Convulsion—Acamprosate—alcohol dependence	0.000664	0.00149	CcSEcCtD
Imiquimod—Angioedema—Naltrexone—alcohol dependence	0.000662	0.00149	CcSEcCtD
Imiquimod—Hypertension—Acamprosate—alcohol dependence	0.000661	0.00149	CcSEcCtD
Imiquimod—Influenza—Citalopram—alcohol dependence	0.000659	0.00148	CcSEcCtD
Imiquimod—Malaise—Naltrexone—alcohol dependence	0.000654	0.00147	CcSEcCtD
Imiquimod—Myalgia—Acamprosate—alcohol dependence	0.000652	0.00147	CcSEcCtD
Imiquimod—Chest pain—Acamprosate—alcohol dependence	0.000652	0.00147	CcSEcCtD
Imiquimod—Arthralgia—Acamprosate—alcohol dependence	0.000652	0.00147	CcSEcCtD
Imiquimod—Syncope—Naltrexone—alcohol dependence	0.00065	0.00146	CcSEcCtD
Imiquimod—Anxiety—Acamprosate—alcohol dependence	0.00065	0.00146	CcSEcCtD
Imiquimod—CYP3A4—liver—alcohol dependence	0.000648	0.00944	CbGeAlD
Imiquimod—CYP3A4—central nervous system—alcohol dependence	0.000648	0.00943	CbGeAlD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000648	0.00146	CcSEcCtD
Imiquimod—Discomfort—Acamprosate—alcohol dependence	0.000644	0.00145	CcSEcCtD
Imiquimod—Sweating increased—Citalopram—alcohol dependence	0.000642	0.00144	CcSEcCtD
Imiquimod—Palpitations—Naltrexone—alcohol dependence	0.000641	0.00144	CcSEcCtD
Imiquimod—Dry mouth—Acamprosate—alcohol dependence	0.000638	0.00143	CcSEcCtD
Imiquimod—Loss of consciousness—Naltrexone—alcohol dependence	0.000637	0.00143	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000635	0.00797	CbGpPWpGaD
Imiquimod—Bronchitis—Citalopram—alcohol dependence	0.000634	0.00143	CcSEcCtD
Imiquimod—Cough—Naltrexone—alcohol dependence	0.000633	0.00142	CcSEcCtD
Imiquimod—Convulsion—Naltrexone—alcohol dependence	0.000628	0.00141	CcSEcCtD
Imiquimod—Pancytopenia—Citalopram—alcohol dependence	0.000626	0.00141	CcSEcCtD
Imiquimod—Hypertension—Naltrexone—alcohol dependence	0.000626	0.00141	CcSEcCtD
Imiquimod—Infection—Acamprosate—alcohol dependence	0.000621	0.0014	CcSEcCtD
Imiquimod—Myalgia—Naltrexone—alcohol dependence	0.000617	0.00139	CcSEcCtD
Imiquimod—Arthralgia—Naltrexone—alcohol dependence	0.000617	0.00139	CcSEcCtD
Imiquimod—Chest pain—Naltrexone—alcohol dependence	0.000617	0.00139	CcSEcCtD
Imiquimod—Dysuria—Citalopram—alcohol dependence	0.000616	0.00139	CcSEcCtD
Imiquimod—Shock—Acamprosate—alcohol dependence	0.000615	0.00138	CcSEcCtD
Imiquimod—Anxiety—Naltrexone—alcohol dependence	0.000615	0.00138	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000613	0.00138	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000613	0.00138	CcSEcCtD
Imiquimod—Tachycardia—Acamprosate—alcohol dependence	0.00061	0.00137	CcSEcCtD
Imiquimod—Discomfort—Naltrexone—alcohol dependence	0.00061	0.00137	CcSEcCtD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000609	0.00765	CbGpPWpGaD
Imiquimod—Skin disorder—Acamprosate—alcohol dependence	0.000607	0.00137	CcSEcCtD
Imiquimod—Erectile dysfunction—Citalopram—alcohol dependence	0.000607	0.00137	CcSEcCtD
Imiquimod—Hyperhidrosis—Acamprosate—alcohol dependence	0.000604	0.00136	CcSEcCtD
Imiquimod—Dry mouth—Naltrexone—alcohol dependence	0.000604	0.00136	CcSEcCtD
Imiquimod—Photosensitivity reaction—Citalopram—alcohol dependence	0.000602	0.00135	CcSEcCtD
Imiquimod—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000598	0.00752	CbGpPWpGaD
Imiquimod—Anorexia—Acamprosate—alcohol dependence	0.000596	0.00134	CcSEcCtD
Imiquimod—Oedema—Naltrexone—alcohol dependence	0.000592	0.00133	CcSEcCtD
Imiquimod—Infection—Naltrexone—alcohol dependence	0.000588	0.00132	CcSEcCtD
Imiquimod—Infestation—Citalopram—alcohol dependence	0.000588	0.00132	CcSEcCtD
Imiquimod—Infestation NOS—Citalopram—alcohol dependence	0.000588	0.00132	CcSEcCtD
Imiquimod—Depression—Citalopram—alcohol dependence	0.000586	0.00132	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000583	0.00131	CcSEcCtD
Imiquimod—Shock—Naltrexone—alcohol dependence	0.000582	0.00131	CcSEcCtD
Imiquimod—Nervous system disorder—Naltrexone—alcohol dependence	0.00058	0.00131	CcSEcCtD
Imiquimod—Acute coronary syndrome—Citalopram—alcohol dependence	0.000579	0.0013	CcSEcCtD
Imiquimod—Tachycardia—Naltrexone—alcohol dependence	0.000577	0.0013	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000576	0.00724	CbGpPWpGaD
Imiquimod—Neuropathy peripheral—Citalopram—alcohol dependence	0.000576	0.0013	CcSEcCtD
Imiquimod—Myocardial infarction—Citalopram—alcohol dependence	0.000576	0.0013	CcSEcCtD
Imiquimod—Skin disorder—Naltrexone—alcohol dependence	0.000575	0.00129	CcSEcCtD
Imiquimod—Hyperhidrosis—Naltrexone—alcohol dependence	0.000572	0.00129	CcSEcCtD
Imiquimod—Conjunctivitis—Citalopram—alcohol dependence	0.000571	0.00129	CcSEcCtD
Imiquimod—Urinary tract infection—Citalopram—alcohol dependence	0.000571	0.00129	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00057	0.00128	CcSEcCtD
Imiquimod—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000569	0.00715	CbGpPWpGaD
Imiquimod—Insomnia—Acamprosate—alcohol dependence	0.000566	0.00127	CcSEcCtD
Imiquimod—Anorexia—Naltrexone—alcohol dependence	0.000564	0.00127	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.000563	0.00707	CbGpPWpGaD
Imiquimod—Paraesthesia—Acamprosate—alcohol dependence	0.000561	0.00126	CcSEcCtD
Imiquimod—TLR7—Immune System—WASF2—alcohol dependence	0.000561	0.00705	CbGpPWpGaD
Imiquimod—Dyspnoea—Acamprosate—alcohol dependence	0.000557	0.00125	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000557	0.00699	CbGpPWpGaD
Imiquimod—Somnolence—Acamprosate—alcohol dependence	0.000556	0.00125	CcSEcCtD
Imiquimod—Hepatobiliary disease—Citalopram—alcohol dependence	0.000556	0.00125	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.000553	0.00694	CbGpPWpGaD
Imiquimod—Sinusitis—Citalopram—alcohol dependence	0.000551	0.00124	CcSEcCtD
Imiquimod—Dyspepsia—Acamprosate—alcohol dependence	0.00055	0.00124	CcSEcCtD
Imiquimod—Decreased appetite—Acamprosate—alcohol dependence	0.000544	0.00122	CcSEcCtD
Imiquimod—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000543	0.00682	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00054	0.00121	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000539	0.00121	CcSEcCtD
Imiquimod—TLR7—Immune System—WASF1—alcohol dependence	0.000538	0.00676	CbGpPWpGaD
Imiquimod—Insomnia—Naltrexone—alcohol dependence	0.000535	0.0012	CcSEcCtD
Imiquimod—Pain—Acamprosate—alcohol dependence	0.000535	0.0012	CcSEcCtD
Imiquimod—Paraesthesia—Naltrexone—alcohol dependence	0.000531	0.00119	CcSEcCtD
Imiquimod—Haemoglobin—Citalopram—alcohol dependence	0.00053	0.00119	CcSEcCtD
Imiquimod—Rhinitis—Citalopram—alcohol dependence	0.000529	0.00119	CcSEcCtD
Imiquimod—Haemorrhage—Citalopram—alcohol dependence	0.000528	0.00119	CcSEcCtD
Imiquimod—Dyspnoea—Naltrexone—alcohol dependence	0.000527	0.00119	CcSEcCtD
Imiquimod—Somnolence—Naltrexone—alcohol dependence	0.000526	0.00118	CcSEcCtD
Imiquimod—Pharyngitis—Citalopram—alcohol dependence	0.000524	0.00118	CcSEcCtD
Imiquimod—Urinary tract disorder—Citalopram—alcohol dependence	0.000521	0.00117	CcSEcCtD
Imiquimod—Connective tissue disorder—Citalopram—alcohol dependence	0.000518	0.00117	CcSEcCtD
Imiquimod—Urethral disorder—Citalopram—alcohol dependence	0.000517	0.00116	CcSEcCtD
Imiquimod—Feeling abnormal—Acamprosate—alcohol dependence	0.000515	0.00116	CcSEcCtD
Imiquimod—Decreased appetite—Naltrexone—alcohol dependence	0.000514	0.00116	CcSEcCtD
Imiquimod—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000511	0.00115	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000511	0.00115	CcSEcCtD
Imiquimod—Fatigue—Naltrexone—alcohol dependence	0.00051	0.00115	CcSEcCtD
Imiquimod—Visual impairment—Citalopram—alcohol dependence	0.000508	0.00114	CcSEcCtD
Imiquimod—Pain—Naltrexone—alcohol dependence	0.000506	0.00114	CcSEcCtD
Imiquimod—Erythema multiforme—Citalopram—alcohol dependence	0.000499	0.00112	CcSEcCtD
Imiquimod—Urticaria—Acamprosate—alcohol dependence	0.000497	0.00112	CcSEcCtD
Imiquimod—Body temperature increased—Acamprosate—alcohol dependence	0.000494	0.00111	CcSEcCtD
Imiquimod—Abdominal pain—Acamprosate—alcohol dependence	0.000494	0.00111	CcSEcCtD
Imiquimod—Eye disorder—Citalopram—alcohol dependence	0.000493	0.00111	CcSEcCtD
Imiquimod—Tinnitus—Citalopram—alcohol dependence	0.000492	0.00111	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00049	0.00615	CbGpPWpGaD
Imiquimod—Flushing—Citalopram—alcohol dependence	0.00049	0.0011	CcSEcCtD
Imiquimod—Feeling abnormal—Naltrexone—alcohol dependence	0.000488	0.0011	CcSEcCtD
Imiquimod—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000484	0.00109	CcSEcCtD
Imiquimod—Angiopathy—Citalopram—alcohol dependence	0.000479	0.00108	CcSEcCtD
Imiquimod—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000478	0.00601	CbGpPWpGaD
Imiquimod—Immune system disorder—Citalopram—alcohol dependence	0.000477	0.00107	CcSEcCtD
Imiquimod—Mediastinal disorder—Citalopram—alcohol dependence	0.000475	0.00107	CcSEcCtD
Imiquimod—Chills—Citalopram—alcohol dependence	0.000473	0.00106	CcSEcCtD
Imiquimod—Arrhythmia—Citalopram—alcohol dependence	0.000471	0.00106	CcSEcCtD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00047	0.00591	CbGpPWpGaD
Imiquimod—Urticaria—Naltrexone—alcohol dependence	0.00047	0.00106	CcSEcCtD
Imiquimod—Abdominal pain—Naltrexone—alcohol dependence	0.000468	0.00105	CcSEcCtD
Imiquimod—Body temperature increased—Naltrexone—alcohol dependence	0.000468	0.00105	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.000466	0.00586	CbGpPWpGaD
Imiquimod—Alopecia—Citalopram—alcohol dependence	0.000466	0.00105	CcSEcCtD
Imiquimod—Mental disorder—Citalopram—alcohol dependence	0.000462	0.00104	CcSEcCtD
Imiquimod—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000462	0.0058	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000461	0.00579	CbGpPWpGaD
Imiquimod—Hypersensitivity—Acamprosate—alcohol dependence	0.000461	0.00104	CcSEcCtD
Imiquimod—Erythema—Citalopram—alcohol dependence	0.000459	0.00103	CcSEcCtD
Imiquimod—Malnutrition—Citalopram—alcohol dependence	0.000459	0.00103	CcSEcCtD
Imiquimod—Asthenia—Acamprosate—alcohol dependence	0.000449	0.00101	CcSEcCtD
Imiquimod—Back pain—Citalopram—alcohol dependence	0.000444	0.000999	CcSEcCtD
Imiquimod—Pruritus—Acamprosate—alcohol dependence	0.000442	0.000995	CcSEcCtD
Imiquimod—Hypersensitivity—Naltrexone—alcohol dependence	0.000436	0.00098	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000434	0.00546	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00043	0.0054	CbGpPWpGaD
Imiquimod—Diarrhoea—Acamprosate—alcohol dependence	0.000428	0.000962	CcSEcCtD
Imiquimod—Ill-defined disorder—Citalopram—alcohol dependence	0.000426	0.000959	CcSEcCtD
Imiquimod—Asthenia—Naltrexone—alcohol dependence	0.000424	0.000955	CcSEcCtD
Imiquimod—Agitation—Citalopram—alcohol dependence	0.000422	0.000949	CcSEcCtD
Imiquimod—Angioedema—Citalopram—alcohol dependence	0.00042	0.000944	CcSEcCtD
Imiquimod—Pruritus—Naltrexone—alcohol dependence	0.000419	0.000941	CcSEcCtD
Imiquimod—Malaise—Citalopram—alcohol dependence	0.000414	0.000932	CcSEcCtD
Imiquimod—Dizziness—Acamprosate—alcohol dependence	0.000413	0.00093	CcSEcCtD
Imiquimod—Syncope—Citalopram—alcohol dependence	0.000412	0.000926	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000411	0.00516	CbGpPWpGaD
Imiquimod—Palpitations—Citalopram—alcohol dependence	0.000406	0.000913	CcSEcCtD
Imiquimod—Diarrhoea—Naltrexone—alcohol dependence	0.000405	0.00091	CcSEcCtD
Imiquimod—Loss of consciousness—Citalopram—alcohol dependence	0.000404	0.000908	CcSEcCtD
Imiquimod—Cough—Citalopram—alcohol dependence	0.000401	0.000902	CcSEcCtD
Imiquimod—Convulsion—Citalopram—alcohol dependence	0.000398	0.000895	CcSEcCtD
Imiquimod—Vomiting—Acamprosate—alcohol dependence	0.000398	0.000894	CcSEcCtD
Imiquimod—Hypertension—Citalopram—alcohol dependence	0.000397	0.000892	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.000397	0.00498	CbGpPWpGaD
Imiquimod—Rash—Acamprosate—alcohol dependence	0.000394	0.000887	CcSEcCtD
Imiquimod—Dermatitis—Acamprosate—alcohol dependence	0.000394	0.000886	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000392	0.00493	CbGpPWpGaD
Imiquimod—Headache—Acamprosate—alcohol dependence	0.000392	0.000881	CcSEcCtD
Imiquimod—Dizziness—Naltrexone—alcohol dependence	0.000391	0.00088	CcSEcCtD
Imiquimod—Chest pain—Citalopram—alcohol dependence	0.000391	0.00088	CcSEcCtD
Imiquimod—Arthralgia—Citalopram—alcohol dependence	0.000391	0.00088	CcSEcCtD
Imiquimod—Myalgia—Citalopram—alcohol dependence	0.000391	0.00088	CcSEcCtD
Imiquimod—Anxiety—Citalopram—alcohol dependence	0.00039	0.000877	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000388	0.000873	CcSEcCtD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000387	0.00486	CbGpPWpGaD
Imiquimod—Discomfort—Citalopram—alcohol dependence	0.000386	0.000869	CcSEcCtD
Imiquimod—Dry mouth—Citalopram—alcohol dependence	0.000382	0.00086	CcSEcCtD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000382	0.00479	CbGpPWpGaD
Imiquimod—Vomiting—Naltrexone—alcohol dependence	0.000376	0.000846	CcSEcCtD
Imiquimod—Oedema—Citalopram—alcohol dependence	0.000375	0.000843	CcSEcCtD
Imiquimod—Rash—Naltrexone—alcohol dependence	0.000373	0.000839	CcSEcCtD
Imiquimod—Dermatitis—Naltrexone—alcohol dependence	0.000373	0.000838	CcSEcCtD
Imiquimod—Infection—Citalopram—alcohol dependence	0.000372	0.000838	CcSEcCtD
Imiquimod—Nausea—Acamprosate—alcohol dependence	0.000371	0.000835	CcSEcCtD
Imiquimod—Headache—Naltrexone—alcohol dependence	0.000371	0.000834	CcSEcCtD
Imiquimod—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000369	0.00464	CbGpPWpGaD
Imiquimod—Shock—Citalopram—alcohol dependence	0.000369	0.00083	CcSEcCtD
Imiquimod—Nervous system disorder—Citalopram—alcohol dependence	0.000368	0.000827	CcSEcCtD
Imiquimod—Tachycardia—Citalopram—alcohol dependence	0.000366	0.000823	CcSEcCtD
Imiquimod—Skin disorder—Citalopram—alcohol dependence	0.000364	0.000819	CcSEcCtD
Imiquimod—Hyperhidrosis—Citalopram—alcohol dependence	0.000362	0.000815	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.00036	0.00452	CbGpPWpGaD
Imiquimod—Anorexia—Citalopram—alcohol dependence	0.000357	0.000804	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000356	0.00447	CbGpPWpGaD
Imiquimod—Nausea—Naltrexone—alcohol dependence	0.000351	0.00079	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000342	0.000768	CcSEcCtD
Imiquimod—Insomnia—Citalopram—alcohol dependence	0.000339	0.000763	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000337	0.00424	CbGpPWpGaD
Imiquimod—Paraesthesia—Citalopram—alcohol dependence	0.000337	0.000757	CcSEcCtD
Imiquimod—Dyspnoea—Citalopram—alcohol dependence	0.000334	0.000752	CcSEcCtD
Imiquimod—Somnolence—Citalopram—alcohol dependence	0.000333	0.00075	CcSEcCtD
Imiquimod—Dyspepsia—Citalopram—alcohol dependence	0.00033	0.000742	CcSEcCtD
Imiquimod—Decreased appetite—Citalopram—alcohol dependence	0.000326	0.000733	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000324	0.000728	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.000323	0.00406	CbGpPWpGaD
Imiquimod—Fatigue—Citalopram—alcohol dependence	0.000323	0.000727	CcSEcCtD
Imiquimod—Pain—Citalopram—alcohol dependence	0.000321	0.000721	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000313	0.00394	CbGpPWpGaD
Imiquimod—Feeling abnormal—Citalopram—alcohol dependence	0.000309	0.000695	CcSEcCtD
Imiquimod—Gastrointestinal pain—Citalopram—alcohol dependence	0.000307	0.000689	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000306	0.00384	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000303	0.0038	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000298	0.00375	CbGpPWpGaD
Imiquimod—Urticaria—Citalopram—alcohol dependence	0.000298	0.00067	CcSEcCtD
Imiquimod—Body temperature increased—Citalopram—alcohol dependence	0.000296	0.000667	CcSEcCtD
Imiquimod—Abdominal pain—Citalopram—alcohol dependence	0.000296	0.000667	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000296	0.00371	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000295	0.0037	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—EP300—alcohol dependence	0.000294	0.0037	CbGpPWpGaD
Imiquimod—Hypersensitivity—Citalopram—alcohol dependence	0.000276	0.000621	CcSEcCtD
Imiquimod—Asthenia—Citalopram—alcohol dependence	0.000269	0.000605	CcSEcCtD
Imiquimod—Pruritus—Citalopram—alcohol dependence	0.000265	0.000597	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000261	0.00328	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.00026	0.00327	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000258	0.00324	CbGpPWpGaD
Imiquimod—Diarrhoea—Citalopram—alcohol dependence	0.000256	0.000577	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000249	0.00313	CbGpPWpGaD
Imiquimod—Dizziness—Citalopram—alcohol dependence	0.000248	0.000558	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000245	0.00308	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000242	0.00304	CbGpPWpGaD
Imiquimod—Vomiting—Citalopram—alcohol dependence	0.000238	0.000536	CcSEcCtD
Imiquimod—Rash—Citalopram—alcohol dependence	0.000236	0.000532	CcSEcCtD
Imiquimod—Dermatitis—Citalopram—alcohol dependence	0.000236	0.000531	CcSEcCtD
Imiquimod—Headache—Citalopram—alcohol dependence	0.000235	0.000528	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000228	0.00287	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—EP300—alcohol dependence	0.000223	0.0028	CbGpPWpGaD
Imiquimod—Nausea—Citalopram—alcohol dependence	0.000223	0.000501	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.000208	0.00262	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000207	0.0026	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000199	0.0025	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000189	0.00238	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EP300—alcohol dependence	0.000171	0.00215	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.00017	0.00214	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.00017	0.00214	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000168	0.00211	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.000167	0.00209	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000164	0.00206	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000161	0.00202	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00016	0.00201	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GGT1—alcohol dependence	0.000153	0.00192	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—MAOA—alcohol dependence	0.000137	0.00172	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EP300—alcohol dependence	0.00013	0.00163	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.00013	0.00163	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000129	0.00161	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000127	0.00159	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000118	0.00148	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000106	0.00133	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADH6—alcohol dependence	9.62e-05	0.00121	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—POMC—alcohol dependence	8.92e-05	0.00112	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADH1A—alcohol dependence	7.98e-05	0.001	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADH6—alcohol dependence	7.43e-05	0.000933	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—POMC—alcohol dependence	6.88e-05	0.000865	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADH4—alcohol dependence	6.78e-05	0.000852	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADH1A—alcohol dependence	6.15e-05	0.000773	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	5.87e-05	0.000738	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADH7—alcohol dependence	5.77e-05	0.000724	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GGT2—alcohol dependence	5.53e-05	0.000695	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADH4—alcohol dependence	5.23e-05	0.000658	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADH1B—alcohol dependence	5.06e-05	0.000635	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADH7—alcohol dependence	4.45e-05	0.000559	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GGT2—alcohol dependence	4.27e-05	0.000536	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MAOB—alcohol dependence	4.19e-05	0.000526	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.9e-05	0.00049	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALDH2—alcohol dependence	3.56e-05	0.000448	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.43e-05	0.00043	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MAOB—alcohol dependence	3.23e-05	0.000406	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GOT2—alcohol dependence	3.03e-05	0.000381	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2E1—alcohol dependence	2.85e-05	0.000358	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.75e-05	0.000345	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GOT1—alcohol dependence	2.61e-05	0.000328	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GGT1—alcohol dependence	2.61e-05	0.000328	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MAOA—alcohol dependence	2.34e-05	0.000294	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GOT2—alcohol dependence	2.34e-05	0.000294	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.27e-05	0.000285	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.2e-05	0.000276	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GGT1—alcohol dependence	2.02e-05	0.000254	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GOT1—alcohol dependence	2.02e-05	0.000254	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MAOA—alcohol dependence	1.81e-05	0.000227	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—POMC—alcohol dependence	1.53e-05	0.000192	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—POMC—alcohol dependence	1.18e-05	0.000148	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—EP300—alcohol dependence	1.01e-05	0.000127	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—EP300—alcohol dependence	7.81e-06	9.81e-05	CbGpPWpGaD
